SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 103.89-0.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cytokine1 who wrote (747)10/19/1998 11:17:00 AM
From: Rocketman  Read Replies (1) of 3202
 
Got this one out of todays BioCentury dated 8/19/98. I find no record of it being announced anywhere else at INCY or Amgen, can't find any Synteni reference to this deal either. It isn't mentioned in the 1/26/98 BioCentury either, just that INCY acquired Synteni. Still need to see if it is mentioned in any INCY SEC filings:

<<<<<<<<<<<
Amgen Inc. (AMGN), Thousand Oaks, Calif.
Incyte Pharmaceuticals Inc. (INCY), Palo Alto, Calif.
Business: Enabling technology
The companies expanded a January agreement on microarray
technology between AMGN and Synteni Inc. (Fremont, Calif.) prior
to INCY's acquisition of Synteni (see BioCentury, Jan. 26). As ex-panded, AMGN will receive broader access to the microarray
technology.
>>>>>>>>>>>

What other secrets are out there?

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext